Asia Latin America Central & Eastern Europe, Western Asia, and Africa

For further Value in Health Regional Issues features, such as Articles in Press, videos, etc., and to view past Value in Health Regional Issues volumes, view the Value in Health Regional Issues HealthAdvance page at Elsevier.

Volume 4 (SEPTEMBER/OCTOBER 2014)

Editorial Board

Featured Article
Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe
In this article, Golicki et al. estimated an interim EQ-5D-5L value set for Poland based on crosswalk methodology developed by the EuroQol Group.

Issue Highlights

ECONOMIC STUDY

Social Cost of Substance Abuse in Russia
In this article, Elena Potapchik and Larisa Popovich estimate the social costs of alcohol, tobacco, and illicit drug abuse in Russia to inform policy makers of the real economic burden of risky behaviors and provide conditions for evidence-based and well-informed decision making in this area.

Medical and Productivity Costs of Rheumatoid Arthritis in The Czech Republic: Cost-of-Illness Study Based on Disease Severity
Klimeš et al. discovered that direct and productivity costs for patients with rheumatoid arthritis (RA) are closely related to the value of the Health Assessment Questionnaire (HAQ) score.

HEALTH POLICY STUDY

Health Economic Data Requirements and Availability in the European Union: Results of a Survey Among 10 European Countries
In this article, Skoupá et al. review the results of a survey conducted among 10 European countries which suggest that there is a clear alignment in CEE countries to UK guidelines, mainly in the type of the analysis and the outcome (QALY) used, and by using a health care system perspective.
Health Care Financing in Ethiopia: Implications on Access to Essential Medicines
In this article, Ali highlights the components of the Ethiopian health care financing reform and discusses its implications on access to essential medicines.
Also in this Issue

EDITORIAL

What Are the Challenges in Conducting Cost-of-Illness Studies?

ECONOMIC STUDY

Cost-Effectiveness Comparison of Fidaxomicin and Vancomycin for Treatment of Clostridium difficile Infection: A Markov Model Based on Data from a South West Balkan Country in Socioeconomic Transition

The Cost of Melanoma and Kidney, Prostate, and Ovarian Cancers in Russia

Work Productivity and Costs Related to Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis

Estimation of the Direct Cost of HIV-Infected Patients in Greece on an Annual Basis

Health Facility Cost of Buruli Ulcer Wound Treatment in Ghana: A Case Study

Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements: A Markov Model

PATIENT-REPORTED OUTCOMES (PRO) OR QUALITY OF LIFE (QOL) STUDY

Use of the EQ-5D Instrument and Value Scale in Comparing Health States of Patients in Four Health Care Programs among Health Care Providers

Mapping the Nottingham Health Profile onto the Preference- Based EuroQol-5D Instrument for Patients with Diabetes

HEALTH POLICY ANALYSIS

Investigating the Economic Impacts of New Public Pharmaceutical Policies in Greece: Focusing on Price Reductions and Cost-Sharing Rates

An Overview of the Orphan Medicines Market in Turkey

Determinants of Cost-Related Nonadherence to Medications among Chronically Ill Patients in Maccabi Healthcare Services, Israel

The Role of the National Health Insurance Fund Administration in the Development of Health Economics and Health Technology Assessment in Hungary

CONCEPTUAL PAPERS

Cost-effectiveness versus Cost-Utility Analyses: What Are the Motives Behind Using Each and How Do Their Results Differ?–A Polish Example

 

Reviewers' Acknowledgement

Previous Issues